Clinical Trials Browser

Phase 2 × Antibodies × Tumor-Agnostic × Clear all

NCT02458638 2021-06-04

A Study of Atezolizumab in Advanced Solid Tumors

Phase 2 Completed

474 enrolled 14 charts

Neoplasms